These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37327593)

  • 1. Magnetic resonance imaging for prospective assessment of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
    Kirshenboim Z; Dan Lantsman C; Appel S; Klug M; Onn A; Truong MT; Marom EM
    Lung Cancer; 2023 Aug; 182():107265. PubMed ID: 37327593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study of Magnetic Resonance Imaging Assessment of Post-radiation Changes Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer.
    Munoz-Schuffenegger P; Kandel S; Alibhai Z; Hope A; Bezjak A; Sun A; Simeonov A; Cho BCJ; Giuliani M
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):720-727. PubMed ID: 31176537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
    Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of treatment response after lung stereotactic body radiotherapy using diffusion weighted magnetic resonance imaging and positron emission tomography: A pilot study.
    Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Umeoka S; Nakamoto Y; Mizowaki T; Togashi K; Hiraoka M
    Eur J Radiol; 2017 Jul; 92():58-63. PubMed ID: 28624021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.
    Zhang X; Liu H; Balter P; Allen PK; Komaki R; Pan T; Chuang HH; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1558-65. PubMed ID: 22572078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of clinical outcome after stereotactic body radiotherapy for non-small cell lung cancer using diffusion-weighted MRI and (18)F-FDG PET.
    Iizuka Y; Matsuo Y; Umeoka S; Nakamoto Y; Ueki N; Mizowaki T; Togashi K; Hiraoka M
    Eur J Radiol; 2014 Nov; 83(11):2087-92. PubMed ID: 25174774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
    Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Mizowaki T
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1228-1236. PubMed ID: 29722662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients.
    Huang YS; Chen JL; Hsu FM; Huang JY; Ko WC; Chen YC; Jaw FS; Yen RF; Chang YC
    J Magn Reson Imaging; 2018 Jan; 47(1):191-199. PubMed ID: 28480541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Local Recurrence on Cause-Specific Death After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Dynamic Prediction Using Landmark Model.
    Ueki K; Matsuo Y; Takeda A; Morita S; Taguri M; Kishi N; Hanazawa H; Tsurugai Y; Mizowaki T
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1135-1143. PubMed ID: 34838867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Peulen H; Mantel F; Guckenberger M; Belderbos J; Werner-Wasik M; Hope A; Giuliani M; Grills I; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):134-41. PubMed ID: 27325481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.
    Sittenfeld SMC; Juloori A; Reddy CA; Stephans KL; Videtic GMM
    Clin Lung Cancer; 2021 May; 22(3):e360-e365. PubMed ID: 32624412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Du S; He J; Zeng Z
    Technol Cancer Res Treat; 2022; 21():15330338221112287. PubMed ID: 35816375
    [No Abstract]   [Full Text] [Related]  

  • 14. Magnetic resonance imaging radiomic features for recurrent prostate cancer following proton radiation therapy-A pilot study.
    Bazargani S; Feibus AH; Elshafei A; Al-Toubat M; Gopireddy DR; Gautam S; Barwari S; Henderson R; Lall C; Balaji KC; Bandyk M
    Urol Oncol; 2023 Mar; 41(3):145.e1-145.e5. PubMed ID: 36496342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
    Watanabe K; Katsui K; Sugiyama S; Yoshio K; Kuroda M; Hiraki T; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    Radiat Oncol; 2021 Feb; 16(1):39. PubMed ID: 33622369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.
    Takeda A; Kunieda E; Fujii H; Yokosuka N; Aoki Y; Oooka Y; Oku Y; Ohashi T; Sanuki N; Mizuno T; Ozawa Y
    Lung Cancer; 2013 Mar; 79(3):248-53. PubMed ID: 23246123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.
    Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ
    Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.
    Hearn JW; Videtic GM; Djemil T; Stephans KL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):402-6. PubMed ID: 25017480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer: Importance of Salvage Surgery.
    Hamaji M; Chen F; Matsuo Y; Ueki N; Hiraoka M; Date H
    J Thorac Oncol; 2015 Nov; 10(11):1616-24. PubMed ID: 26317918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.